U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07559526) titled 'Nutritional Assessment of Patients With Non-small Cell Lung Cancer Treated With Osimertinib' on April 24.
Brief Summary: Nutritional assessment of patients with non-small cell lung cancer treated with osimertinib.
Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases and is a leading cause of morbidity and mortality worldwide. Between 35% and 65% of NSCLC patients experience nutritional problems or malnutrition, which significantly affects their prognosis and quality of life. This study aims to describe the nutritional status and body composition of NSCLC patients treated with osimertinib, an oral...